Suzanne Scheele

发表

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project.

C. Dye, V. Pathania, M. Raviglione, 1999, JAMA.

Evaluating the impact of tuberculosis control: number of deaths prevented by short-course chemotherapy in China.

C. Dye, Brett Williams, S. Scheele, 2000, International journal of epidemiology.

Global burden of tuberculosis

Christopher Dye, Vikram Pathania, C. Dye, 1999 .

SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of Toxoplasma gondii CDPK1

Dustin J Maly, W. Hol, M. Parsons, 2015, ACS medicinal chemistry letters.

Potent and selective inhibitors of CDPK1 from T. gondii and C. parvum based on a 5-aminopyrazole-4-carboxamide scaffold.

Dustin J Maly, K. Comess, C. Verlinde, 2014, ACS medicinal chemistry letters.

Measuring tuberculosis burden, trends, and the impact of control programmes.

B G Williams, H L Rieder, C. Dye, 2008, The Lancet. Infectious diseases.

What Drives the Value of a Shigella Vaccine?

B. Giersing, William P. Hausdorff, S. Scheele, 2022, Vaccines.

Projecting the long-term economic benefits of reducing Shigella-attributable linear growth faltering with a potential vaccine: a modelling study

K. Bagamian, William P. Hausdorff, John D. Anderson, 2023, The Lancet. Global health.

Potential impact and cost-effectiveness of Shigella vaccination in 102 low-income and middle-income countries in children aged 5 years or younger: a modelling study

K. Bagamian, William P. Hausdorff, John D. Anderson, 2023, The Lancet. Global health.